FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹487 Cr | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr |
What is the latest Total Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹487 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹257 Cr |
| Mar2022 | ₹187 Cr |
| Mar2021 | ₹162 Cr |
How is Total Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹487 Cr | 58.21 | |
| Mar2024 | ₹308 Cr | 19.56 | |
| Mar2023 | ₹257 Cr | 37.59 | |
| Mar2022 | ₹187 Cr | 15.70 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹900.3 Cr | -5.7% | 12.9% | 140.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -5.7% |
12.9% |
140.7% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses